(17E)-1alpha,25-dihydroxy-17,20-didehydro-21-norvitamin D3 / (17E)-1alpha,25-dihydroxy-17,20-didehydro-21-norcholecalciferol

(1R,3S,5Z)-5-[(2E)-2-[(1E,3aS,7aS)-1-(5-hydroxy-5-methylhexylidene)-7a-methyl-2,3,3a,5,6,7-hexahydroinden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

WAQLIOVKGGWXKO-BSEONHEZSA-N CHEBI:184186 0 Reactome links 1 studies

Metabolite details

Identifier: WAQLIOVKGGWXKO-BSEONHEZSA-N
InChI Key: WAQLIOVKGGWXKO-BSEONHEZSA-N
IUPAC name: (1R,3S,5Z)-5-[(2E)-2-[(1E,3aS,7aS)-1-(5-hydroxy-5-methylhexylidene)-7a-methyl-2,3,3a,5,6,7-hexahydroinden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
Preferred name: (17E)-1alpha,25-dihydroxy-17,20-didehydro-21-norvitamin D3 / (17E)-1alpha,25-dihydroxy-17,20-didehydro-21-norcholecalciferol
INN name: —
Synonym: —
ChEBI: CHEBI:184186

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation

Observed in differential profiles

Control_vs_Exercise